1
|
Ghallab DS, Shawky E, Metwally AM, Celik I, Ibrahim RS, Mohyeldin MM. Integrated in silico - in vitro strategy for the discovery of potential xanthine oxidase inhibitors from Egyptian propolis and their synergistic effect with allopurinol and febuxostat. RSC Adv 2022; 12:2843-2872. [PMID: 35425287 PMCID: PMC8979054 DOI: 10.1039/d1ra08011c] [Citation(s) in RCA: 17] [Impact Index Per Article: 8.5] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/01/2021] [Accepted: 01/04/2022] [Indexed: 01/19/2023] Open
Abstract
Xanthine oxidase (XO) has been well-recognized as a validated target for the treatment of hyperuricemia and gout. Currently, there are two drugs in clinical use that shut down XO overactivity, allopurinol and febuxostat; however, detrimental side effects restrict their applications. Propolis is a unique natural adhesive biomass of structurally variable and biologically active metabolites that exert remarkable health benefits. Moreover, combination drug therapy has become a promising pharmacotherapeutic strategy directed for reformulating existing drugs into new combination entities with potentiating therapeutic impacts. In this study, computer-aided molecular docking and MD simulations accompanied by biochemical testing were used for mining novel pharmacologically active chemical entities from Egyptian propolis to combat hyperuricemia. Further, with a view to decrease the potential toxicity of synthetic drugs and enhance efficacy, propolis hits were subjected to combination analysis with each of allopurinol and febuxostat. More specifically, Glide docking was utilized for a structure-based virtual screening of in-house datasets comprising various Egyptian propolis metabolites. Rosmarinic acid, luteolin, techtochrysin and isoferulic acid were the most promising virtual hits. In vitro XO inhibitory assays demonstrated the ability of these hits to significantly inhibit XO in a dose-dependent manner. Molecular docking and MD simulations revealed a cooperative binding mode between the discovered hits and standard XO inhibitors within the active site. Subsequently, the most promising hits were tested in a fixed-ratio combination setting with allopurinol and febuxostat separately to assess their combined effects on XO catalytic inhibition. The binary combination of each techtochrysin and rosmarinic acid with febuxostat displayed maximal synergy at lower effect levels. In contrast, individually, techtochrysin and rosmarinic acid with allopurinol cooperated synergistically at high dose levels. Taken together, the suggested strategy seems imperative to ensure a steady supply of new therapeutic options sourced from Egyptian propolis to regress the development of hyperuricemia.
Collapse
Affiliation(s)
- Dina S Ghallab
- Department of Pharmacognosy, Faculty of Pharmacy, Alexandria University Alexandria 21521 Egypt +20-1223821098
| | - Eman Shawky
- Department of Pharmacognosy, Faculty of Pharmacy, Alexandria University Alexandria 21521 Egypt +20-1223821098
| | - Ali M Metwally
- Department of Pharmacognosy, Faculty of Pharmacy, Alexandria University Alexandria 21521 Egypt +20-1223821098
| | - Ismail Celik
- Department of Pharmaceutical Chemistry, Faculty of Pharmacy, Erciyes University Kayseri 38039 Turkey
| | - Reham S Ibrahim
- Department of Pharmacognosy, Faculty of Pharmacy, Alexandria University Alexandria 21521 Egypt +20-1223821098
| | - Mohamed M Mohyeldin
- Department of Pharmacognosy, Faculty of Pharmacy, Alexandria University Alexandria 21521 Egypt +20-1223821098
| |
Collapse
|
2
|
Yücel A, Yücel H, Aydemir F, Cüre E, Eryılmaz MA, Çizmecioğlu HA, Küçük A. Determination of hearing levels in gout patients and factors affecting hearing levels such as the dislipidemia, hemoglobin levels and hyperuricemia. Am J Otolaryngol 2020; 41:102565. [PMID: 32563785 DOI: 10.1016/j.amjoto.2020.102565] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/13/2020] [Revised: 05/01/2020] [Accepted: 05/24/2020] [Indexed: 02/07/2023]
Affiliation(s)
- Abitter Yücel
- Department of Otorhinolaryngology Head and Neck Surgery, Konya Health Application and Research Center, University of Health Sciences Turkey, Konya, Turkey.
| | - Hilal Yücel
- Department of Otorhinolaryngology Head and Neck Surgery, Konya Training and Research Hospital, University of Health Sciences Turkey, Konya, Turkey
| | - Fuat Aydemir
- Department of Otorhinolaryngology Head and Neck Surgery, Kulu State Hospital, Konya, Turkey
| | - Erkan Cüre
- Department of Internal Medicine, Ota & Jinemed Hospital, Istanbul, Turkey
| | - Mehmet Akif Eryılmaz
- Department of Otorhinolaryngology Head and Neck Surgery, Necmettin Erbakan University, Meram Faculty of Medicine, Konya, Turkey
| | - Hilal Akay Çizmecioğlu
- Department of Internal Medicine, Necmettin Erbakan University, Meram Faculty of Medicine, Konya, Turkey
| | - Adem Küçük
- Department of Rheumatology, Necmettin Erbakan University, Meram Faculty of Medicine, Konya, Turkey
| |
Collapse
|
3
|
Zhang Y, Jiang J, Zhang Z, Yu H, Rong S, Gao H, Pan H, Chang D. Electrochemical strategy with zeolitic imidazolate framework-8 and ordered mesoporous carbon for detection of xanthine. IET Nanobiotechnol 2020; 14:120-125. [PMID: 32433028 DOI: 10.1049/iet-nbt.2018.5342] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/19/2022] Open
Abstract
An accurate, safe, environmentally friendly, fast and sensitive electrochemical biosensors were developed to detect xanthine in serum. The metal-organic framework ZIF-8 was synthesised and elemental gold was supported on the surface of ZIF-8 by reduction method to synthesise Ag-ZIF-8. The mesoporous carbon material and the synthesised Ag-ZIF-8 were, respectively, applied to a glassy carbon electrode to construct biosensors. The constructed biosensor has a good linear relation in the range of 1-280 μmol l-1 of xanthine and the detection limit is 0.167 μmol l-1. The relative standard deviation value in serum samples was <5%, and the recoveries were 96-106%, indicating the good selectivity, stability and reproducibility of this electrochemical biosensor.
Collapse
Affiliation(s)
- Yingcong Zhang
- Department of Clinical Laboratory, Shanghai Pudong Hospital, Fudan University Pudong Medical Center, Shanghai 201399, People's Republic of China
| | - Jinghui Jiang
- The First Affiliated Hospital of the Harbin Medical University, Heilongjiang Province 150001, People's Republic of China
| | - Ze Zhang
- Department of Clinical Laboratory, Shanghai Pudong Hospital, Fudan University Pudong Medical Center, Shanghai 201399, People's Republic of China
| | - Hongwei Yu
- Department of Clinical Laboratory, Shanghai Pudong Hospital, Fudan University Pudong Medical Center, Shanghai 201399, People's Republic of China
| | - Shengzhong Rong
- Public Health School, Mudanjiang Medical University, Mudanjiang, Heilongjiang 157011, People's Republic of China
| | - Hongmin Gao
- School of Public Health, Wuhan University of Science and Technology, HuBei Province 430065, People's Republic of China
| | - Hongzhi Pan
- Collaborative Research Center, Shanghai University of Medicine and Health Sciences, Shanghai 201399, People's Republic of China
| | - Dong Chang
- Department of Clinical Laboratory, Shanghai Pudong Hospital, Fudan University Pudong Medical Center, Shanghai 201399, People's Republic of China.
| |
Collapse
|
4
|
Rossato MF, Hoffmeister C, Trevisan G, Bezerra F, Cunha TM, Ferreira J, Silva CR. Monosodium urate crystal interleukin-1β release is dependent on Toll-like receptor 4 and transient receptor potential V1 activation. Rheumatology (Oxford) 2020; 59:233-242. [PMID: 31298290 DOI: 10.1093/rheumatology/kez259] [Citation(s) in RCA: 5] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/10/2019] [Revised: 05/03/2019] [Indexed: 01/19/2023] Open
Abstract
OBJECTIVE The present study aimed to elucidate the mechanisms involved in MSU-induced IL-1β release in a rodent animal model of acute gout arthritis. METHODS Painful (mechanical and thermal hypersensitivity, ongoing pain and arthritis score) and inflammatory (oedema, plasma extravasation, cell infiltration and IL-1β release) parameters were assessed several hours after intra-articular injection of MSU (100 µg/articulation) in wild-type or knockout mice for Toll-like receptor 4 (TLR4), inducible nitric oxide synthase (iNOS), transient receptor potential (TRP) V1 and the IL-1 receptor (IL-1R). Also, wild-type animals were treated with clodronate, lipopolysaccharide from Rhodobacter sphaeroides (LPS-RS) (TLR4 antagonist), spleen tyrosine kinase (SYK) inhibitor (iSYK), aminoguanidine (AMG, an iNOS inhibitor) or SB366791 (TRPV1 antagonist). Nitrite/nitrate and IL-1β levels were measured on the synovial fluid of wild-type mice, 2 h after intra-articular MSU injections, or medium from macrophages stimulated for MSU (1000 μg) for 2 h. RESULTS Intra-articular MSU injection caused robust nociception and severe inflammation from 2 up to 6 h after injection, which were prevented by the pre-treatment with clodronate, LPS-RS, iSYK, AMG and SB366791, or the genetic ablation of TLR4, iNOS, TRPV1 or IL-1R. MSU also increased nitrite/nitrate and IL-1β levels in the synovial fluid, which was prevented by clodronate, LPS-RS, iSYK and AMG, but not by SB366791. Similarly, MSU-stimulated peritoneal macrophages released nitric oxide, which was prevented by LPS-RS, iSYK and AMG, but not by SB366791, and released IL-1β, which was prevented by LPS-RS, iSYK, AMG and SB366791. CONCLUSION Our data indicate that MSU may activate TLR4, SYK, iNOS and TRPV1 to induce the release of IL-1β by macrophages, triggering nociception and inflammation during acute gout attack.
Collapse
Affiliation(s)
- Mateus F Rossato
- Graduated Program in Pharmacology, Department of Pharmacology, Ribeirão Preto Medical School, University of São Paulo, Ribeirão Preto, São Paulo, Brazil
| | - Carin Hoffmeister
- Graduated Program in Pharmacology, Biochemistry and Molecular Biology Department, Federal University of Santa Maria (UFSM), Santa Maria, Rio Grande do Sul, Brazil
| | - Gabriela Trevisan
- Graduated Program in Pharmacology, Biochemistry and Molecular Biology Department, Federal University of Santa Maria (UFSM), Santa Maria, Rio Grande do Sul, Brazil
| | - Fabio Bezerra
- Graduated Program in Pharmacology, Department of Pharmacology, Ribeirão Preto Medical School, University of São Paulo, Ribeirão Preto, São Paulo, Brazil
| | - Thiago M Cunha
- Graduated Program in Pharmacology, Department of Pharmacology, Ribeirão Preto Medical School, University of São Paulo, Ribeirão Preto, São Paulo, Brazil
| | - Juliano Ferreira
- Graduated Program in Pharmacology, Pharmacology Department, Federal University of Santa Catarina (UFSC), Florianopolis, Santa Catarina, Brazil
| | - Cassia R Silva
- Graduated Program in Genetics and Biochemistry, Biotechnology Institute, Federal University of Uberlândia, Uberlândia, Minas Gerais, Brazil
| |
Collapse
|
5
|
Wang Z, Wang X, Yan H, Liu Y, Li L, Li S, Wang X, Wang D. Aronia melanocarpa ameliorates gout and hyperuricemia in animal models. FOOD AGR IMMUNOL 2018. [DOI: 10.1080/09540105.2018.1541967] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/27/2022] Open
Affiliation(s)
- Zhuqian Wang
- School of Life Sciences, Jilin University, Changchun, People’s Republic of China
| | - Xi Wang
- School of Life Sciences, Jilin University, Changchun, People’s Republic of China
| | - Han Yan
- School of Life Sciences, Jilin University, Changchun, People’s Republic of China
| | - Yan Liu
- School of Life Sciences, Jilin University, Changchun, People’s Republic of China
| | - Lanzhou Li
- School of Life Sciences, Jilin University, Changchun, People’s Republic of China
| | - Shaopeng Li
- School of Pharmacy and Food Science, Zhuhai College of Jilin University, Jilin University, Zhuhai, People’s Republic of China
| | - Xiaofeng Wang
- Department of Stomatology, China–Japan Union Hospital of Jilin University, Jilin University, Changchun, People’s Republic of China
| | - Di Wang
- School of Life Sciences, Jilin University, Changchun, People’s Republic of China
- School of Pharmacy and Food Science, Zhuhai College of Jilin University, Jilin University, Zhuhai, People’s Republic of China
| |
Collapse
|
6
|
Pagidipati NJ, Clare RM, Keenan RT, Chiswell K, Roe MT, Hess CN. Association of Gout With Long-Term Cardiovascular Outcomes Among Patients With Obstructive Coronary Artery Disease. J Am Heart Assoc 2018; 7:e009328. [PMID: 30369327 PMCID: PMC6201404 DOI: 10.1161/jaha.118.009328] [Citation(s) in RCA: 23] [Impact Index Per Article: 3.8] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 03/29/2018] [Accepted: 07/03/2018] [Indexed: 12/15/2022]
Abstract
Background Epidemiological studies demonstrating a relationship between gout and cardiovascular disease are older and predate modern cardiovascular preventive therapy. We assessed the contemporary association between gout and cardiovascular disease in patients with obstructive coronary artery disease. Methods and Results Data were from the Duke Databank for Cardiovascular Diseases, which followed up patients undergoing cardiac catheterization with obstructive coronary artery disease at Duke University Medical Center (1998-2013). We assessed the relationship between gout diagnosis at baseline or during follow-up and the primary composite outcome of cardiovascular death, myocardial infarction, or stroke, adjusting for differences in baseline clinical factors. Secondary end points included cardiovascular death and all-cause mortality. New, postbaseline, gout diagnosis was included as a time-dependent covariate. Among 17 201 patients, 1406 (8.2%) had baseline gout and a high burden of cardiovascular risk factors, but high rates of optimal medical therapy. Over a median follow-up of 6.4 years, gout diagnosis at time of catheterization was not associated with the primary outcome (hazard ratio [95% confidence interval], 1.05 [0.96-1.15]; P=0.31) or cardiovascular death (hazard ratio [95% confidence interval], 1.10 [0.99-1.22]; P=0.08), but was associated with increased all-cause mortality (hazard ratio [95% confidence interval], 1.13 [1.05-1.23]; P=0.002). After including new, postbaseline, gout diagnosis, the instantaneous risk of the primary outcome was significantly associated with prior gout diagnosis (hazard ratio [95% confidence interval], 1.15 [1.07-1.25]; P=0.0004). Conclusions A clinical history of gout is associated with worse outcomes in a contemporary population of patients with obstructive coronary artery disease. This increased risk exists despite high levels of optimal baseline cardiovascular disease medical therapy, suggesting that residual cardiovascular risk is not addressed by standard medical therapy.
Collapse
Affiliation(s)
- Neha J. Pagidipati
- Duke Clinical Research InstituteDuke University School of MedicineDurhamNC
| | - Robert M. Clare
- Duke Clinical Research InstituteDuke University School of MedicineDurhamNC
| | - Robert T. Keenan
- Duke Clinical Research InstituteDuke University School of MedicineDurhamNC
| | - Karen Chiswell
- Duke Clinical Research InstituteDuke University School of MedicineDurhamNC
| | - Matthew T. Roe
- Duke Clinical Research InstituteDuke University School of MedicineDurhamNC
| | - Connie N. Hess
- University of Colorado School of MedicineAuroraCO
- CPC Clinical ResearchAuroraCO
| |
Collapse
|
7
|
Li LY, Ma RL, Du L, Wu AS. Ozonated autohemotherapy modulates the serum levels of inflammatory cytokines in gouty patients. Open Access Rheumatol 2017; 9:159-165. [PMID: 28860878 PMCID: PMC5565251 DOI: 10.2147/oarrr.s119749] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/18/2022] Open
Abstract
Objectives Ozonated autohemotherapy (O3-AHT) has been used to effectively treat gout, but the underlying therapeutic mechanisms remain unknown. In this study, as an initial effort to understand the therapeutic mechanisms of O3-AHT, we aim to examine the effect of O3-AHT on serum inflammatory cytokine levels in gouty patients. Patients and methods Three groups of patients and healthy subjects were recruited, including the gouty (n=10), hyperuricemia (n=10), and healthy control (n=11) groups. Cytometric bead array was applied to examine 12 cytokines before (T0), during (T1), and after (T2) therapies. Results Three cytokines, IL-8, IL-12, and MCP-1, were detectable in all participants. Before O3-AHT, the average serum levels of IL-8 and MCP-1 were higher in the gout group than in the hyperuricemia and healthy control groups, confirming the inflammation status in gouty patients. After the 5th course of O3-AHT (T1), IL-8 level was significantly increased compared to that at T0. IL-12 level was also raised at T1, although the difference did not reach statistical significance. After completing the therapy, both IL-8 and IL-12 levels decreased to levels lower than those at T0. MCP-1 level remained essentially unchanged during and after treatment. Conclusion Our results indicate that O3-AHT induces a significant change in serum cytokine levels, suggesting that modulating the inflammatory process is one of the therapeutic mechanisms underlying O3-AHT. In addition, the sensitive response of serum IL-8 and IL-12 levels to O3-AHT suggests that these cytokines may be developed as biomarkers to evaluate the therapeutic effect of O3-AHT in gouty patients.
Collapse
Affiliation(s)
- Lian-Yun Li
- Department of Anesthesiology, Dongfang Hospital of Beijing University of Chinese Medicine.,Department of Pain, Beijing Electric Power Hospital
| | - Ruo-Lan Ma
- Department of Anesthesiology, Beijing Stomatological Hospital, Capital Medical University, Beijing, People's Republic of China
| | - Liqin Du
- Department of Chemistry & Biochemistry, Texas State University, San Marcos, TX, USA
| | - An-Shi Wu
- Department of Anesthesiology, Beijing Chao-Yang Hospital, Capital Medical University, Beijing, People's Republic of China
| |
Collapse
|
8
|
Ruoff G, Edwards NL. Overview of Serum Uric Acid Treatment Targets in Gout: Why Less Than 6 mg/dL? Postgrad Med 2016; 128:706-15. [DOI: 10.1080/00325481.2016.1221732] [Citation(s) in RCA: 25] [Impact Index Per Article: 3.1] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/20/2022]
Affiliation(s)
- Gary Ruoff
- Department of Family Practice, Michigan State University, Kalamazoo, MI, USA
| | | |
Collapse
|
9
|
Chinchilla SP, Urionaguena I, Perez-Ruiz F. Febuxostat for the chronic management of hyperuricemia in patients with gout. Expert Rev Clin Pharmacol 2016; 9:665-73. [DOI: 10.1586/17512433.2016.1162094] [Citation(s) in RCA: 21] [Impact Index Per Article: 2.6] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/08/2022]
|